Recently Updated
- 12/15/2009
- Medical Abortion Guidebook
- 11/05/2009
- List of Mifepristone Approval
- 11/04/2009
- Map of Mifepristone Approval
- 05/25/2009
- Clinical Studies List
- 05/04/2009
- Medical Abortion Program Brief
Resources by Title
Abortion and sex determination
Abortion in the Middle East and North Africa
Acceptability and feasibility of medical abortion in Nepal
Alternatives to mifepristone for early medical abortion
Alternatives to Routine Follow-Up for Early Medical Abortion
Annotated Bibliography - Mifepristone Medical Abortion
Annotated Bibliography - Misoprostol for Early Abortion
Are two doses of misoprostol after mifepristone for early abortion better than one?
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Blood Loss After Vaginal Delivery
Can mifepristone medical abortion be simplified?
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Clostridium sordellii infection in medical abortion
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Community-based kangaroo mother care to prevent neonatal and infant mortality
Comparison of serum markers for thrombophilia and autoimmune disease
Expanding Choice in Abortion Services in Armenia
FAQ on Hormonal Contraception and HIV
FAQs on Fatal Infection and Medical Abortion - Summary
FAQs on Fatal Infection and Medical Abortion - Technical Version
Fever after treatment of postpartum hemorrhage
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Home administration of misoprostol for early medical abortion in India
Improving Current Therapies and Exploring New Options in Abortifacient Technology
Increasing women’s choices in medical abortion in Turkey
Integrating medical abortion into safe abortion services in South Africa
Issue Brief on Hormonal Contraception and HIV
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Materials Development Activities Brief
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Medical Abortion Program Brief
Methotrexate compared to misoprostol alone for early medical abortion
Mifepristone for late first trimester abortion
Mifepristone medical abortion in Albania
Misoprostol and Teratogenicity: Reviewing the Evidence
Misoprostol for Early Abortion
Misoprostol for Incomplete Abortion and Miscarriage
Misoprostol for incomplete abortion in Burkina Faso
Misoprostol for incomplete abortion in Mozambique
Misoprostol for incomplete abortion in Tanzania
Misoprostol for Prevention of Postpartum Hemorrhage
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Misoprostol for Women’s Health
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Misoprostol PPH Treatment Study
Misoprostol to treat missed abortion in the first trimester
Misoprostol: A New Addition to Post Abortion Care
Non-physician clinicians can safely provide first trimester medical abortion
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Outlook Newsletter on Hormonal Contraception and HIV
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Perspectives on reproductive decision-making amongst HIV-infected individuals
Policy and Advocacy Activities Brief
Postpartum Hemorrhage Program Brief
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Postpartum Hemorrhage: Responding to the Challenge
PPH Misoprostol Adjunct Treatment Study
PPH Prevention Study in Pakistan
PPH Treatment Study in Pakistan
Pregnancy Failure and Miscarriage Program Brief
Prevention of postpartum hemorrhage with misoprostol
Reference List - Misoprostol for Early Abortion
Reference List - Misoprostol for Incomplete Abortion and Miscarriage
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
Regimens of misoprostol with mifepristone for early medical abortion
Relationship of Hormonal Contraception to HIV
Reproductive intentions among HIV-positive women and men
Route of Misoprostol Administration
Social Science Research Activities Brief
STIs/ HIV/ Infectious Disease Program Brief
Sublingual misoprostol after mifepristone
Sublingual misoprostol for incomplete abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Supervision for use of mifepristone medical abortion
Technical Assistance Activities Brief
The supreme court and the partial-birth abortion ban act of 2003
Training and Education Activities Brief
Treatment of incomplete abortion and miscarriage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Two distinct oral routes of misoprostol in mifepristone medical abortion
Use of sequential serum hCG and sonography for medical abortion only when indicated